Lars Thaning

Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial

Andreas Hermes, Bengt Bergman, Roy M. Bremnes et al. · Journal of Clinical Oncology · 2008 · 166 citations · Full text

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial

Martin Helsing, Bengt Bergman, Lars Thaning et al. · European Journal of Cancer · 1998 · 127 citations

Palliative Care, Oncology, Cancer Management +5

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

Andrea Koch, Bengt Bergman, Erik Holmberg et al. · European Journal of Cancer · 2011 · 61 citations

Medicine, Pathology, Bronchial Neoplasm +7

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial

Gunnar Westman, Bengt Bergman, M. Albertsson et al. · European Journal of Cancer · 1999 · 60 citations

Megestrol Acetate, Endocrine Oncology, Oncology +12

In the shadow of bad news – views of patients with acute leukaemia, myeloma or lung cancer about information, from diagnosis to cure or death

Lena Hoff, Ulf Tidefelt, Lars Thaning et al. · BMC Palliative Care · 2007 · 48 citations · Full text